O
PHGE icon

OrbiMed’s BiomX PHGE Stock Holding History

OrbiMed’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-94,093
Closed -$993K – 114
2025
Q1 		$993K Hold
94,093
– – 0.02% 101
2024
Q4 		$1.31M Hold
94,093
– – 0.03% 108
2024
Q3 		$1.82M Buy
94,093
+21,600
+30% +$783K 0.03% 109
2024
Q2 		$4.63M Buy
72,493
+48,716
+205% +$3.28M 0.09% 92
2024
Q1 		$2.03M Hold
23,777
– – 0.04% 104
2023
Q4 		$1.26M Sell
23,777
-189
-0.8% -$11.9K 0.03% 102
2023
Q3 		$1.6M Hold
23,966
– – 0.03% 115
2023
Q2 		$1.64M Buy
23,966
+7,327
+44% +$425K 0.03% 118
2023
Q1 		$964K Buy
16,639
+1,831
+12% +$116K 0.02% 116
2022
Q4 		$525K Hold
14,808
– – 0.01% 114
2022
Q3 		$957K Hold
14,808
– – 0.02% 128
2022
Q2 		$2.05M Hold
14,808
– – 0.04% 131
2022
Q1 		$5.43M Hold
14,808
– – 0.09% 119
2021
Q4 		$4.5M Hold
14,808
– – 0.06% 137
2021
Q3 		$8.61M Buy
14,808
+2,632
+22% +$2.04M 0.09% 134
2021
Q2 		$12.6M Hold
12,176
– – 0.13% 115
2021
Q1 		$16.5M Hold
12,176
– – 0.15% 106
2020
Q4 		$14.8M Hold
12,176
– – 0.13% 112
2020
Q3 		$14.7M Hold
12,176
– – 0.18% 99
2020
Q2 		$12.8M Hold
12,176
– – 0.18% 90
2020
Q1 		$16.2M Hold
12,176
– – 0.27% 75
2019
Q4 		$22.4M Buy
+12,176
New +$21M 0.32% 62

Other funds holding PHGE

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

OrbiMed's PHGE Position: Q2 2025 in Review

OrbiMed sold out of BiomX (PHGE) in Q2 2025, closing a stake of 94,093 shares — an estimated $993K sold.

OrbiMed first reported a position in PHGE in Q4 2019 and held it in 22 quarters. The position peaked at $22.4M in Q4 2019. 18 funds tracked by Wall St. Rank hold PHGE as of Q2 2025.

  • OrbiMed reported no remaining BiomX position as of Q2 2025 after selling out during the quarter.
  • OrbiMed sold 94,093 BiomX shares in Q2 2025, an estimated $993K.
  • OrbiMed first reported a position in BiomX in Q4 2019 and held it in 22 quarters.
  • OrbiMed's BiomX position peaked at $22.4M in Q4 2019.
  • 18 funds tracked by Wall St. Rank held BiomX as of Q2 2025.

Based on OrbiMed's 13F filing for Q2 2025, filed 14 Aug 2025.